RYVENT
Generic: CARBINOXAMINE MALEATE
Carwin Pharmaceutical AssociatesManufacturer
ORALRoute
CARBINOXAMINE MALEATEActive Substance
2016-05-31Original Approval
RYVENT is FDA application ANDA207484, sponsored by PHARMOBEDIENT. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG TOXICITY
14 reports
2
DRUG INEFFECTIVE
9 reports
3
FATIGUE
7 reports
4
HEADACHE
7 reports
5
PAIN
7 reports
6
UNRESPONSIVE TO STIMULI
7 reports
7
DIZZINESS
6 reports
8
LOSS OF CONSCIOUSNESS
6 reports
9
PYREXIA
6 reports
10
ANXIETY
5 reports